David Roth - Jul 7, 2022 Form 3 Insider Report for Allarity Therapeutics, Inc. (ALLR)

Role: Director
Signature: /s/ David Roth
Stock symbol: ALLR
Transactions as of: Jul 7, 2022
Transactions value $: $0
Form type: 3
Date filed: 7/11/2022, 05:15 PM
Previous filing: Apr 4, 2022
Next filing: Oct 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALLR	Stock Options							Jul 7, 2022	Common Stock	23K	$1.28	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the Issuer's 2021 Equity Incentive Plan (the "Plan"), the Reporting Person was granted 23,000 non-qualified stock options (the "Options") at the exercise price of $1.28. The Options were granted on July 7, 2022 (the "Grant Date"), and vest 1/36 per month over a three year period commencing as of the Grant Date. The Options were granted to the Reporting Person, who is a non-executive director of the Issuer, in a transaction exempt under Rule 16b-3 to the Reporting Person.

Content

Pursuant to the Issuer's 2021 Equity Incentive Plan (the "Plan"), the Reporting Person was granted 23,000 non-qualified stock options (the "Options") at the exercise price of $1.28. The Options were granted on July 7, 2022 (the "Grant Date"), and vest 1/36 per month over a three year period commencing as of the Grant Date. The Options were granted to the Reporting Person, who is a non-executive director of the Issuer, in a transaction exempt under Rule 16b-3 to the Reporting Person.